Prof Julio Rosenstock (UT Southwestern Medical Center, Dallas, US) discusses CARMELINA - Cardiovascular and renal microvascular outcome study linagliptin in patients with type 2 diabetes mellitus.
Filmed by Radcliffe Cardiology on site at EASD 2018.
Interviewer: Rob Barclay
Videographer: Mike Knight